Abstract
Tumour radioiodine concentration has been compared with serum thyroglobulin (Tg) and, in a few cases, with tumour complement of thyrotrophin receptors in patients with differentiated thyroid carcinoma. All tumours examined possessed TSH receptors. In most the complement was similar to that of normal thyroid tissue although all but one of the tumours had no detectable 131I concentration in vivo even with excess TSH stimulation. Elevated serum Tg (patient taking T4 in suppressive dose) was generally associated with tumours which had 131I concentrating function when stimulated by excess TSH. Some patients, however, had high serum Tg concentration but only low or indetectable tumour 131I uptake. We conclude that (a) measurement of tumour TSH receptor complement is unlikely to be useful in clinical management as tumours which do not significantly concentrate 131I in vivo may have a normal TSH receptor complement and (b) the capacity to secrete Tg is usually associated with 131I concentration but quantitatively the relationship varies considerably between tumours.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abe Y., Ichikawa Y., Muraki T., Ito K., Homma M. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma. J Clin Endocrinol Metab. 1981 Jan;52(1):23–28. doi: 10.1210/jcem-52-1-23. [DOI] [PubMed] [Google Scholar]
- Carayon P., Thomas-Morvan C., Castanas E., Tubiana M. Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. J Clin Endocrinol Metab. 1980 Oct;51(4):915–920. doi: 10.1210/jcem-51-4-915. [DOI] [PubMed] [Google Scholar]
- Edmonds C. J., Hayes S., Kermode J. C., Thompson B. D. Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine. Br J Radiol. 1977 Nov;50(599):799–807. doi: 10.1259/0007-1285-50-599-799. [DOI] [PubMed] [Google Scholar]
- Kermode J. C., Edmonds C. J., Morgans M. E. Receptors for thyroid-stimulating hormone in normal and pathological human thyroid tissues. J Endocrinol. 1984 Sep;102(3):369–374. doi: 10.1677/joe.0.1020369. [DOI] [PubMed] [Google Scholar]
- Kermode J. C., Thompson B. D., Edmonds C. J. Comparison of binding of bovine and human thyroid-stimulating hormone to receptor sites on human thyroid membranes. J Endocrinol. 1981 Feb;88(2):205–217. doi: 10.1677/joe.0.0880205. [DOI] [PubMed] [Google Scholar]
- Kermode J. C., Thompson B. D. Iodination of thyroid-stimulating hormone for receptor-binding studies with human thyroid membranes: effects of specific activity and method of iodination. J Endocrinol. 1980 Mar;84(3):439–447. doi: 10.1677/joe.0.0840439. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Ng Tang Fui S. C., Hoffenberg R., Maisey M. N., Black E. G. Serum thyroglobulin concentrations and whole-body radioiodine scan in follow-up of differentiated thyroid cancer after thyroid ablation. Br Med J. 1979 Aug 4;2(6185):298–300. doi: 10.1136/bmj.2.6185.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schneider A. B., Ikekubo K., Kuma K. Iodine content of serum thyroglobulin in normal individuals and patients with thyroid tumors. J Clin Endocrinol Metab. 1983 Dec;57(6):1251–1256. doi: 10.1210/jcem-57-6-1251. [DOI] [PubMed] [Google Scholar]
- Smith B. R., Hall R. Binding of thyroid stimulators to thyroid membranes. FEBS Lett. 1974 Jun 15;42(3):301–304. doi: 10.1016/0014-5793(74)80751-9. [DOI] [PubMed] [Google Scholar]
- Takahashi H., Jiang N. S., Gorman C. A., Lee C. Y. Thyrotropin receptors in normal and pathological human thyroid tissues. J Clin Endocrinol Metab. 1978 Oct;47(4):870–876. doi: 10.1210/jcem-47-4-870. [DOI] [PubMed] [Google Scholar]